Ene I. Ette, Ph.D., FCP, FCCP

President and CEO

Dr. Ette has over 26 years of broad experience in academia, drug evaluation and regulation, and the pharmaceutical industry. He has a Ph.D. in Clinical Pharmacology, an MBA, an M.S. in pharmacology, a B.S. in pharmacology, and a B.S. in pharmacy. A prolific author of several original articles in peer-reviewed journals, book chapters, numerous conference presentations and proceedings, Dr. Ette is on the editorial board of many clinical pharmacology / pharmacy journals as well as a referee for many biomedical journals. He is primary the editor of the classic pharmacometrics reference text, Pharmacometrics: the Science of Quantitative Pharmacology. He is also an invited speaker at many international clinical pharmacology/ pharmacy, pharmaceutical science, and statistical meetings.

Dr. Ette is a fellow of the American Colleges of Clinical Pharmacology and Clinical Pharmacy. He is the 2006 recipient of the American College of Clinical Pharmacy’s Therapeutic Frontier Lecture Award for distinguished scientists. He was a consultant to FDA from 1998 to 2001. In 1999 he was the recipient of the American College of Clinical Pharmacy’s prestigious Russell Miller Award for outstanding contributions to the clinical pharmacy literature; and in 1996 the recipient of Excellence in Review Science Award in CDER (FDA). At the FDA he was the major author of the Guidance for Industry: Population Pharmacokinetics.

He is an adjunct professor of applied pharmaceutical sciences at the University of Rhode Island’s College of Pharmacy and the University of the Pacific’s Thomas J. Long School of Pharmacy and Allied Health Sciences. Before now, he was the Senior Director/Head, Clinical Pharmacology, Vertex Pharmaceuticals, Cambridge, MA. where he introduced and championed efforts in the integration of knowledge-based (pharmacometric modeling and simulation) principles into drug development. Before taking up appointment at Vertex he was a leading pharmocometrician in the Office of Clinical Pharmacology, Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). He has broad experience academia, drug evaluation and regulation, and the pharmaceutical industry. Moreover, he has broad experience in the evaluation and development of drugs. He is a holder of patents.